Patents by Inventor Qianjia YUAN

Qianjia YUAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240400517
    Abstract: A chiral bimetallic cooperative catalysis system and use thereof in asymmetric synthesis of bedaquiline are provided. Specifically, the chiral bimetallic cooperative catalysis system is formed by a metallic lithium, sodium or potassium salt and another metal salt under the action of a suitable ligand and an additive. By means of the chiral bimetallic cooperative catalysis system, an addition reaction of 6-bromo-3-benzyl-2-methoxyquinoline (I) and 3-dimethylamino-1-naphthyl-1-propanone (II) is promoted, the selectivity is regulated, and a target product, (1R,2S)-bedaquiline, with high yield and high selectivity is obtained for the first time.
    Type: Application
    Filed: March 17, 2023
    Publication date: December 5, 2024
    Applicant: SHANGHAI JIAO TONG UNIVERSITY
    Inventors: Wanbin ZHANG, Feng GAO, Jing LI, Tanveer AHMAD, Zhenfeng ZHANG, Qianjia YUAN
  • Patent number: 11655255
    Abstract: A method for catalytic asymmetric synthesis of a phosphorus-stereogenic (P-stereogenic) nucleoside derivative of formula (3) and a catalyst used therein. The P-stereogenic nucleoside derivative (3) can be hydrolyzed to obtain remdesivir.
    Type: Grant
    Filed: October 17, 2022
    Date of Patent: May 23, 2023
    Assignees: SPH NO.1 BIOCHEMICAL & PHARMACEUTICAL CO., LTD., Shanghai Jiaotong University
    Inventors: Wanbin Zhang, Mo Wang, Lu Zhang, Xiaohong Huo, Zhenfeng Zhang, Qianjia Yuan, Jianzhong Chen
  • Publication number: 20230085986
    Abstract: A method for catalytic asymmetric synthesis of a phosphorus-stereogenic (P-stereogenic) nucleoside derivative of formula (3) and a catalyst used therein. The P-stereogenic nucleoside derivative (3) can be hydrolyzed to obtain remdesivir. Specifically, a nucleoside and phosphoryl chloride are subjected to asymmetric reaction under the catalysis of a chiral bicyclic imidazole catalyst in the presence of a base to produce the P-stereogenic nucleoside derivative.
    Type: Application
    Filed: October 17, 2022
    Publication date: March 23, 2023
    Inventors: Wanbin ZHANG, Mo WANG, Lu ZHANG, Xiaohong HUO, Zhenfeng ZHANG, Qianjia YUAN, Jianzhong CHEN